Euthymics Bioscience

Euthymics Bioscience is a clinical-stage company focused on neuroscience, dedicated to developing next-generation treatments for depression. Euthymics’ initial focus is on patients who do not respond adequately to SSRIs. Euthymics is developing products targeting moderate neurological disorders, including Major Depressive Disorder (MDD), as well as alcohol use disorder in collaboration with the government.